Ifosfamide nephrotoxicity in pediatric cancer patients

Pediatric Nephrology

Volumn 16, Issue 10, 2001, Pages 796-799

  Lee, B S ^a   Lee, J H ^a   Kang, H G ^a   Hahn, H ^a   Shin, H Y ^a   Ha, I S ^a   Cheong, H I ^a   Ahn, H S ^a   Choi, Y ^a  

^a Seoul National University Children's Hospital   (South Korea)

Author keywords

Cisplatin; Ifosfamide; Nephrotoxicity; 2 Microglobulinuria

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; BETA 2 MICROGLOBULIN; BICARBONATE; BIOCHEMICAL MARKER; CARBOPLATIN; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; GLUCOSE; IFOSFAMIDE; MESNA; PHOSPHATE; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BICARBONATE BLOOD LEVEL; BLADDER DISEASE; CANCER PATIENT; CHILDHOOD CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG MEGADOSE; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCOSE URINE LEVEL; GLUCOSURIA; HEMORRHAGIC CYSTITIS; HUMAN; HYPOCAPNIA; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEPHROTOXICITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; HUMANS; IFOSFAMIDE; INFANT; KIDNEY DISEASES; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034820648     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670100658     Document Type: Article

References (33)

1. Ifosfamide, mesna, and nephrotoxicity in children
2. Ifosfamide-induced nephrotoxicity in children: Critical review of predictive risk factors
3. Iphosphamide-induced nephrotoxicity in children
4. The influence of age on nephrotoxicity following chemotherapy in children
5. Renal function abnormalities after ifosfamide treatment in children
6. Risk factors for ifosfamide nephrotoxicity in children
7. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum
8. Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum (II) therapy
9. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: Analysis of 120 patients
10. Ifosfamide, Fanconi's syndrome, and rickets
11. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor
12. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents
13. Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells
14. Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna
15. Concentrating capacity in ifosfamide-induced severe renal dysfunction
16. Renal dysfunctions secondary to ifosfamide treatment in children
17. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children
18. Severe renal failure following high-dose ifosfamide and mesna
19. Ifosfamide nephrotoxicity in paediatric cancer patients
20. Nephrotoxicity after ifosfamide
21. Estimation of ifosfamide/cisplatin-induced renal toxicity by urinary protein analysis
22. Assessment of maximal tubular phosphate reabsorption: Comparison of direct measurement with the nomogram of Bijvoet
23. Estimation of glomerular filtration rate in anorectic adolescents
24. Long-term follow-up ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: An international society of pediatric oncology report
25. Renal toxicity of cancer chemotherapeutic agents in children: Ifosfamide and cisplatin
26. Cisplatin therapy in childhood: Renal follow up 3 years or more after treatment
27. 2-microglobulin and N-acetyl-β-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum (II)
28. The long-term effect of cisplatin on renal function
29. Long-term renal effect of cisplatin in man
30. Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture
31. Effect of ifosfamide metabolites on sodium-dependant phosphate transport in a model of proximal tubular cells (LLC-PK1) in culture
32. Deletions in the mitochondrial DNA and decrease in the oxidative phosphorylation activity of children with Fanconi syndrome secondary to antiblastic therapy
33. Development of ifosfamide-induced nephrotoxicity: Prospective follow-up in 75 patients